Susan Dorman, MD

Faculty

Titles:

Associate Professor, Medicine

SciVal:

SciVal Link

Dr. Dorman and her research team at JHU focus on the development and assessment of new tuberculosis diagnostic tests and strategies and new tuberculosis treatment strategies.  Her team’s multidisciplinary work in tuberculosis diagnostics includes test development, accuracy assessments, implementation research, economic evaluations, and mathematical modeling.  Dr. Dorman serves as co-Principal investigator with Dr. Jerrold Ellner on a U.S. National Institutes of Health-funded contract, the ‘Tuberculosis Clinical Diagnostics Research Consortium’, whose mission is to conduct early stage assessments of novel diagnostic tests for tuberculosis at study sites in China, South Korea, South Africa, Kenya, Uganda, and Brazil.  She also serves as Principal Investigator on phase I, II, and III clinical trials of rifapentine, including multicenter international trials of the CDC Tuberculosis Trials Consortium. 

Categories

Events

«

September 2019

»
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·
·
·
·

Projects

mHealth for improved TB contact investigation...

This multicenter randomized study is evaluating the implementation, effectiveness, cost-effectiveness, and population-level...

Read More

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More

APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More